Guaranteeing access to medicines is a goal for all Latin American countries. However, implementing regulations that not only allow more affordable prices but also mitigate the risks of shortages and facilitate their control can become a real challenge.

The characteristics, strengths, weaknesses, and results of drug price regulation in a middle-income country like El Salvador are, in this context, of great interest to governments that seek to strengthen their pharmaceutical policy in moving towards coverage. universal health